Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Fridays vs Gala

Gala costs $100 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Fridays logo

Fridays

5.5
★★★☆☆2.8/5

Best for: coaching bundled into the price rather than sold separately

Visit Fridays →
VS
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →

If you are choosing between Fridays and Gala, the first difference is cost: Gala is $100 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Gala leads our six-part score, 8.7 to 5.5.

Fridays vs Gala price

Gala is the cheaper way in: $149 a month against $249 a month at Fridays. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Gala ($179 a month vs $249 a month); tirzepatide is cheaper at Gala ($149 a month vs $359 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections and brand-name pens.

Where each one treats patients

Fridays does not publish where it ships, and Gala lists 50 states.

Pricing

Fridays

Month-to-month, compoundedCompounded
$249/mo
semaglutide
Month-to-month, compoundedCompounded
$359/mo
tirzepatide
Ozempic®, name-brand injectionBrand-name
$1498/mo
semaglutide
Zepbound®, name-brand injectionBrand-name
$1828/mo
tirzepatide

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

What each price covers

Both prices cover the clinician visit and the medication itself.

Fridays' price also covers coaching, which Gala does not claim.

Gala's price also covers shipping, which Fridays does not claim.

Fridays is silent on shipping and lab work.

Gala is silent on lab work and coaching.

Fridays

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Gala scores 8.7 and Fridays 5.5 out of 10.

Gala is stronger on value (8.7 vs 2.8), user experience (8.0 vs 3.0), trust & safety (7.5 vs 4.0) and accessibility (10.0 vs 5.0).

Effectiveness and support are within half a point.

How we score

Fridays

5.5/10

Overall

Gala

8.7/10

Value25%

2.8A
vs
B
8.7

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

4.0A
vs
B
7.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

FDA warning letters

Neither Fridays nor Gala has an FDA warning letter on record with us.

Features & Coverage

FeatureFridaysGala
Starting Price$249/mo✓$149/mo
Features2 features✓7 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Fridays

Fridays is a telehealth weight loss seller running compounded GLP-1 programs.

Read our full Fridays review →

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

Pros & Cons

Fridays

What we like

  • The monthly price includes the medication, clinician visits and coaching
  • We found no FDA warning letters issued to Fridays

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Gala

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Gala

Gala wins this one, 8.7 to 5.5, above all for moving between compounded and brand without changing seller. It also costs $100 less each month than Fridays. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.

Choose Fridays if…

You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

Fridays vs Gala: FAQ

Gala. It starts at $149 a month; Fridays starts at $249 a month, $100 more per month.
Yes, both sell semaglutide and tirzepatide.
Fridays does not publish where it ships; Gala lists 50 states. Confirm your state before paying.
Both include the clinician visit and the medication itself. Only Fridays includes coaching. Only Gala includes shipping.
Fridays has none. Gala has none.
Gala pays us a commission on sign-ups through our links; Fridays does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.